Results 141 to 150 of about 621,376 (215)

Detection of Tn-antigen in breast and prostate cancer models by VVL-labeled red dye-doped nanoparticles. [PDF]

Nanomedicine (Lond)
Verhassel A, Kimani M, Gidwani K, Sandholm J, Gawlitza K, Rurack K, Härkönen P.   +6 more
europepmc   +1 more source

Globohexaosylceramide (globo-H); ganglioside GM2 (GM2); Thomsen-Friedenreich antigen (TF); Tn antigen (Tn); sialosyl-Tn antigen (sTn) [PDF]

Science-Business eXchange, 2009
openaire   +1 more source

Specific Identification of Glycoproteins Bearing the Tn Antigen in Human Cells. [PDF]

Angew Chem Int Ed Engl, 2017
Zheng J, Xiao H, Wu R.
europepmc   +1 more source

Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation. [PDF]

J Cell Mol Med, 2019
Liu Z, Liu J, Dong X, Hu X, Jiang Y, Li L, Du T, Yang L, Wen T, An G, Feng G.   +10 more
europepmc   +1 more source

Different expression of Tn and sialyl-Tn antigens between normal and diseased human gastric epithelial cells.

Thomsen-Friedenreich antigen (T antigen) has been supposed to be a cancer-specific carbohydrate antigen. We have previously shown that one third of the Japanese population normally expressed T antigen in gastric surface epithelia and the other two thirds
Tsuji, Takao, Nakatou, Tatsuaki, Sotozono, Masaaki, Yoshida, Atushi, Okada, Yoshio   +4 more
core  

Sialyl-Tn Antigen Antibody [PDF]

, 2020
openaire   +1 more source

Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen. [PDF]

J Biol Chem, 2012
Mi R, Song L, Wang Y, Ding X, Zeng J, Lehoux S, Aryal RP, Wang J, Crew VK, van Die I, Chapman AB, Cummings RD, Ju T.   +12 more
europepmc   +1 more source

IgM promotes antitumor immunity to a Tn-expressing solid tumor. [PDF]

J Immunother Cancer
Nzuki HL, Jennings-Gee JE, Trivette M, Mosher TH, Adams-Sims AE, Hegarty AA, Haas KM.   +6 more
europepmc   +1 more source

A cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity. [PDF]

Angew Chem Int Ed Engl, 2014
Richichi B, Thomas B, Fiore M, Bosco R, Qureshi H, Nativi C, Renaudet O, BenMohamed L.   +7 more
europepmc   +1 more source

CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance. [PDF]

Cancer Immunol Res
King-Peoples TR, Keane JT, Lewis HS, Liu F, Brookens SK, Dagher OK, Parvathaneni K, Gardner BL, Ahmed A, Furth EE, Lal P, Posey AD.   +11 more
europepmc   +1 more source